Targeting Free Radicals in Oxidative Stress-Related Human Diseases
- PMID: 28551354
- DOI: 10.1016/j.tips.2017.04.005
Targeting Free Radicals in Oxidative Stress-Related Human Diseases
Abstract
Cancer and Alzheimer's disease (AD) are characterized by (i) opposing biological mechanisms, (ii) an inverse correlation between their incidences, and (iii) oxidative stress being a common denominator of both diseases. Increased formation of reactive oxygen species (ROS) in cancer cells from oncogenic signaling and/or metabolic disturbances leads to upregulation of cellular antioxidant capacity to maintain ROS levels below a toxic threshold. Combining drugs that induce high levels of ROS with compounds that suppress cellular antioxidant capacity by depleting antioxidant systems [glutathione (GSH), superoxide dismutase (SOD), and thioredoxin (TRX)] and/or targeting glucose metabolism represents a potential anticancer strategy. In AD, free metals and/or Aβ:metal complexes may cause damage to biomolecules in the brain (via Fenton reaction), including DNA. Metal chelation, based on the application of selective metal chelators or metal delivery, may induce neuroprotective signaling and represents a promising therapeutic strategy. This review examines therapeutic strategies based on the modulation of oxidative stress in cancer and AD.
Keywords: Alzheimer’s disease; ROS; antioxidants; cancer; oxidative stress.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Similar articles
-
Free radicals, metals and antioxidants in oxidative stress-induced cancer.Chem Biol Interact. 2006 Mar 10;160(1):1-40. doi: 10.1016/j.cbi.2005.12.009. Epub 2006 Jan 23. Chem Biol Interact. 2006. PMID: 16430879 Review.
-
Advances in metal-induced oxidative stress and human disease.Toxicology. 2011 May 10;283(2-3):65-87. doi: 10.1016/j.tox.2011.03.001. Epub 2011 Mar 23. Toxicology. 2011. PMID: 21414382 Review.
-
Redox- and non-redox-metal-induced formation of free radicals and their role in human disease.Arch Toxicol. 2016 Jan;90(1):1-37. doi: 10.1007/s00204-015-1579-5. Epub 2015 Sep 7. Arch Toxicol. 2016. PMID: 26343967 Review.
-
Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease.Adv Drug Deliv Rev. 2008 Oct-Nov;60(13-14):1463-70. doi: 10.1016/j.addr.2008.04.015. Epub 2008 Jul 4. Adv Drug Deliv Rev. 2008. PMID: 18655815 Review.
-
Lipoic acid as a novel treatment for Alzheimer's disease and related dementias.Pharmacol Ther. 2007 Jan;113(1):154-64. doi: 10.1016/j.pharmthera.2006.07.001. Epub 2006 Sep 20. Pharmacol Ther. 2007. PMID: 16989905 Review.
Cited by
-
Serum Derivatives-Reactive Oxygen Metabolite Levels as a Marker of Clinical Conditions in Patients with Bronchial Asthma, COPD, or Asthma-COPD Overlap: A Prospective Study.J Clin Med. 2024 Oct 9;13(19):6022. doi: 10.3390/jcm13196022. J Clin Med. 2024. PMID: 39408083 Free PMC article.
-
Vulnerability of Antioxidant Drug Therapies on Targeting the Nrf2-Trp53-Jdp2 Axis in Controlling Tumorigenesis.Cells. 2024 Oct 3;13(19):1648. doi: 10.3390/cells13191648. Cells. 2024. PMID: 39404411 Free PMC article. Review.
-
Antioxidant Properties and Vasorelaxant Mechanism of Aqueous Extract of Ricinodendron heudelotii (Euphorbiaceae).Biomed Res Int. 2024 Sep 16;2024:3435974. doi: 10.1155/2024/3435974. eCollection 2024. Biomed Res Int. 2024. PMID: 39314543 Free PMC article.
-
Neuroprotective effect and preparation methods of berberine.Front Pharmacol. 2024 Sep 6;15:1429050. doi: 10.3389/fphar.2024.1429050. eCollection 2024. Front Pharmacol. 2024. PMID: 39309003 Free PMC article. Review.
-
Mechanistic Insights on Metformin and Arginine Implementation as Repurposed Drugs in Glioblastoma Treatment.Int J Mol Sci. 2024 Aug 30;25(17):9460. doi: 10.3390/ijms25179460. Int J Mol Sci. 2024. PMID: 39273414 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical